What Does a Thickened Endometrium Mean?
A thickened endometrium indicates the need for further evaluation to rule out endometrial pathology, with the clinical significance and required workup depending critically on menopausal status and the presence of symptoms.
Clinical Significance by Menopausal Status
Postmenopausal Women
In postmenopausal women, an endometrial thickness ≥5 mm generally prompts evaluation by endometrial tissue sampling 1. This threshold is crucial because:
- An endometrial thickness ≤4 mm conveys a negative predictive value for cancer of nearly 100% 1
- When the endometrium measures ≥5 mm, the primary concern is endometrial cancer, which is the most serious etiology in this population 1
- Ultrasound alone cannot reliably determine the etiology of endometrial thickening 1
For asymptomatic postmenopausal women without bleeding, the threshold is higher. Research suggests that an endometrial thickness >11 mm should prompt biopsy, as this carries approximately a 6.7% risk of cancer, while measurements ≤11 mm carry an extremely low risk of 0.002% 2. However, recent evidence indicates that even in asymptomatic women, the optimal cut-off may be 10.5 mm for general screening 3.
Premenopausal Women
The interpretation is fundamentally different in premenopausal women:
- Normal endometrial thickness varies with the menstrual cycle phase 1
- There is no validated absolute upper limit cutoff for endometrial thickness 1
- Endometrial thickness is not a reliable indicator of endometrial pathology in this population 1
- Even with thickness <5 mm, endometrial polyps or other pathology may be present 1
Differential Diagnosis
A thickened endometrium can represent multiple pathologies:
Benign Causes
- Endometrial polyps (most common benign cause)
- Endometrial hyperplasia (with or without atypia)
- Adenomyosis
- Leiomyomas (submucosal)
- Atrophic endometrium with cystically dilated glands 4
Malignant Causes
- Endometrial cancer (primary concern in postmenopausal women)
- Leiomyosarcoma (rare)
Other Considerations
- Hormonal effects: Tamoxifen therapy, unopposed estrogen exposure
- Physiologic: Normal proliferative phase in premenopausal women
Diagnostic Approach
Initial Imaging
Transvaginal ultrasound (TVUS) is the first-line screening test 1. The examination should include:
- Measurement of endometrial thickness
- Assessment of endometrial echogenicity and texture (abnormalities correlate with significant pathology) 1
- Color Doppler evaluation to identify vascularity patterns 1
When Initial Ultrasound is Inadequate
If the endometrium cannot be completely visualized due to patient body habitus, uterine position, or coexisting pathology (leiomyomas, adenomyosis):
- Sonohysterography can distinguish focal from diffuse pathology and differentiate polyps from leiomyomas with 97% accuracy 1
- MRI with gadolinium and diffusion-weighted imaging can identify malignant pathology with sensitivity/specificity up to 79%/89% for endometrial cancer 1
Tissue Diagnosis
Endometrial sampling or hysteroscopy with biopsy is required for definitive diagnosis 1, as imaging cannot distinguish benign from malignant pathology with sufficient certainty. Office endometrial biopsy (Pipelle device) has 99.6% sensitivity for detecting endometrial carcinoma 5, 6.
Critical Pitfalls to Avoid
Do not rely on endometrial thickness alone in premenopausal women - it is not predictive of pathology 1
Do not assume thin endometrium excludes pathology in symptomatic patients - a negative endometrial biopsy in symptomatic patients requires fractional D&C 7
Recognize that imaging cannot definitively exclude malignancy - tissue diagnosis is essential when thresholds are exceeded 1
Consider special populations: Women on tamoxifen may require higher thresholds (19.5 mm) before intervention 3, and those with Lynch syndrome have 30-60% lifetime risk of endometrial cancer requiring heightened surveillance 5, 7
Abnormal echogenicity and texture matter as much as thickness - these features correlate with significant pathology independent of measurement 1